AbbVie's Skyrizi Adds Crohn's Disease Indication In Europe

 
• By Jessica Merrill
  
approval stamp
AbbVie's Skyrizi is cleared in Europe for Crohn's disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapeutic Category